Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
10/2012
10/09/2012US8283462 Group of nucleic acid fragments for prevention of HIV infection or AIDS and the usage thereof
10/09/2012US8283330 Modulators of pharmacological agents
10/09/2012US8283329 Genetic inhibition of double-stranded RNA
10/09/2012US8283328 nucleotides having modified linkages, used as adjuvants for vaccines useful for treating diseases including cancer, infection, allergies and asthma
10/09/2012US8283321 Kallikrein-binding “Kunitz domain” proteins and analogues thereof
10/09/2012US8283183 Detecting method, detection device and detection kit
10/09/2012US8283181 Capillary pins for high-efficiency microarray printing device
10/09/2012US8283164 Liver engrafting cells, assays, and uses thereof
10/09/2012US8283158 Method and apparatus for performing multiple simultaneous manipulations of biomolecules in a two dimensional array
10/09/2012US8283151 Isolation, cloning and characterization of new adeno-associated virus (AAV) serotypes
10/09/2012US8283148 Reverse transcriptase for use as amplification tool in genome analysis
10/09/2012US8283136 Skin treatment compositions
10/09/2012US8283133 Sterilization indicator
10/09/2012US8283132 Method and devices for treating individual biological cells
10/09/2012US8283122 Prediction of clinical outcome using gene expression profiling and artificial neural networks for patients with neuroblastoma
10/09/2012US8283121 Detection of nucleic acid sequence differences using coupled ligase detection and polymerase chain reactions
10/09/2012US8283120 Noncontact stirring method, noncontact stirring apparatus, method and apparatus for reacting nucleic acid hybridization using the apparatus, method for detecting nucleic acid in sample, apparatus for detecting nucleic acid, method for detecting antibody in sample, apparatus for detecting antibody
10/09/2012US8283119 Methods for determining prognoses and therapeutic interventions for ovarian carcinomas
10/09/2012US8283118 Isolated genomic polynucleotide fragments from chormosome 19 that encode human syntaxin binding protein 2
10/09/2012US8283116 Methods of screening for compounds for treating spinal muscular atrophy using SMN mRNA translation regulation
10/09/2012US8283115 Methods of screening for compounds for treating muscular dystrophy using UTRN mRNA translation regulation
10/09/2012US8283114 Genes of an otitis media isolate of nontypeable Haemophilus influenzae
10/09/2012US8283113 Compositions and methods for preventing and treating cancer via modulating UBE1L, ISG15 and/or UBP43
10/09/2012US8282919 Microorganism strain CRC2631 of Salmonella typhimurium and its use as a cancer therapeutic
10/09/2012CA2494197C Streptococcus uberis protein, nucleic acid sequence encoding the same and its use in a mastitis vaccine
10/09/2012CA2459347C Locked nucleic acid (lna) compositions and uses thereof
10/09/2012CA2432377C Focused libraries of genetic packages
10/09/2012CA2414782C Intron associated with myotonic dystrophy type 2 and methods of use
10/09/2012CA2356207C Gene expression profiling of inflammatory bowel disease
10/09/2012CA2323751C Diagnostics and vaccines for mycobacterial infections of animals and humans
10/09/2012CA2229204C Deubiquitinating enzymes that regulate cell growth
10/09/2012CA2164698C Synthetic peptide inhibitors of hiv transmission
10/04/2012WO2012135845A1 Gene expression signature for wnt/b-catenin signaling pathway and use thereof
10/04/2012WO2012135844A2 Circulating exosomes as diagnostic/prognostic indicators and therapeutic targets of melanoma and other cancers
10/04/2012WO2012135841A2 Emt signatures and predictive markers and method of using the same
10/04/2012WO2012135824A2 Method of screening for colon cancer using biomarkers
10/04/2012WO2012135817A2 Microrna 130a,b as a tumor suppressor and sensitizing agent for chemotherapy
10/04/2012WO2012135815A2 Methods and kits for detecting cell-free pathogen-specific nucleic acids
10/04/2012WO2012135814A2 Microrna29a,b,c as a tumor suppressor and sensitizing agent for chemotherapy
10/04/2012WO2012135766A1 Methods to remove genetic markers
10/04/2012WO2012135730A2 Method for verifying bioassay samples
10/04/2012WO2012135701A2 Compositions and methods for the detection of anaplasma platys
10/04/2012WO2012135696A2 Methods and compositions for the diagnosis, classification, and treatment of cancer
10/04/2012WO2012135667A1 System and method for determining copies-per-unit-volume using pcr and flow control of droplets
10/04/2012WO2012135664A2 Methods and compositions to enable multiplex cold-pcr
10/04/2012WO2012135663A2 Two-stage microfluidic device for acoustic particle manipulation and methods of separation
10/04/2012WO2012135658A2 Sequence preserved dna conversion for optical nanopore sequencing
10/04/2012WO2012135657A2 Compositions and methods for diagnosis, preventing and treating intracranial aneurysms
10/04/2012WO2012135651A1 Systems, models and methods for identifying and evaluating skin-active agents effective for treating dandruff/seborrheic dermatitis
10/04/2012WO2012135620A2 Molecular gram stain
10/04/2012WO2012135549A2 Tlr8 transgenic animals
10/04/2012WO2012135468A2 Genetics of gender discrimination in date palm
10/04/2012WO2012135435A1 Method of screening for cancer by detecting mutations in the delta-catenin coding region
10/04/2012WO2012135416A1 Screening methods for identifying specific staphylococcus aureus inhibitors
10/04/2012WO2012135400A1 Methods for assessment and treatment of mood disorders via single nucleotide polymorphisms analysis
10/04/2012WO2012135397A2 Lactate-and ketones-induced gene signatures and use the same for diagnosing disease and predicting clinical outcome
10/04/2012WO2012135340A2 Compositions and methods for diagnosing cancer
10/04/2012WO2012135327A1 Managing variation in spectroscopic intensity measurements through the use of a reference component
10/04/2012WO2012135146A2 Role of ifng methylation in inflammatory bowel disease
10/04/2012WO2012135144A2 Methods of diagnosing and treating intestinal granulomas and low bone density in inflammatory bowel disease
10/04/2012WO2012135119A1 Biomarker-based detection and treatment of neurodegenerative depression
10/04/2012WO2012135091A2 Serum-based mirna microarray and its use in diagnosis and treatment of barrett's esophagus (be) and esophageal adenocarcinoma (eac)
10/04/2012WO2012135067A1 Cellular response assay for biofluid biomarker discovery and detection
10/04/2012WO2012135053A2 Rnase h-based assays utilizing modified rna monomers
10/04/2012WO2012135008A1 Gene expression predictors of cancer prognosis
10/04/2012WO2012134884A1 Identification of a nucleic acid template in a multiplex sequencing reaction
10/04/2012WO2012134602A2 Methods and systems for sequencing long nucleic acids
10/04/2012WO2012134440A1 Methods and devices for nucleic acid purification
10/04/2012WO2012134195A2 Detection of target nucleic acid sequence by pto cleavage and extension-dependent cleavage
10/04/2012WO2012134104A2 Microbial fuel cell comprising a microprobe array
10/04/2012WO2012134063A2 Primer for detecting pathogenic bacteria of oral bacterial infectious diseases, and use thereof
10/04/2012WO2012133834A1 Sample nucleic acid for single nucleotide polymorphism detection purposes, pcr primer for preparing sample for single nucleotide polymorphism detection purposes, and method for preparing sample for single nucleotide polymorphism detection purposes which can be used in ion exchange chromatographic analysis
10/04/2012WO2012133825A1 Hot flash suppressant
10/04/2012WO2012133761A1 Modified glucose dehydrogenase
10/04/2012WO2012133735A1 Nucleic acid construct containing nucleic acid derived from genotype 1b hcv genome, hcv genome-replicating cells transfected with same, and method for producing infectious hcv particles
10/04/2012WO2012133688A1 Method for detecting cancer cell using fluorescently labeled l-glucose derivative, and cancer cell-imaging agent comprising fluorescently labeled l-glucose derivative
10/04/2012WO2012133674A1 Method for removing tumorigenesis-causing cells among stem cells
10/04/2012WO2012133629A1 Method for producing artificial skin model, and artificial skin model
10/04/2012WO2012133127A1 Method for distinguishing between species in the genus staphylococcus
10/04/2012WO2012132369A1 Viral vector targeting cancer stem cells
10/04/2012WO2012131670A2 Methods for lung cancer clasification
10/04/2012WO2012131616A1 Primer set, kit and methods thereof
10/04/2012WO2012131594A1 Markers associated with cyclin-dependent kinase inhibitors
10/04/2012WO2012131411A1 METHOD FOR COLORIMETRIC DETERMINATION OF cPNMP SPECIFIC ENZYME ACTIVITY VIA COUPLED ENZYMATIC REACTIONS
10/04/2012WO2012131345A2 Enzyme assays
10/04/2012WO2012131300A2 Method for analysing sward
10/04/2012WO2012131217A1 Detection of bacteria having an enzymatic resistance to carbapenems
10/04/2012WO2012131216A1 Detection of bacteria having a resistance to carbapenems
10/04/2012WO2012131167A1 Sample processing apparatus and method
10/04/2012WO2012131099A1 Use of blood or tissue bacteriome for prediction, diagnosis and prevention of metabolic diseases and their cardiovascular complications
10/04/2012WO2012131098A1 Method for predicting abdominal obesity
10/04/2012WO2012131092A2 Method and kits for the prediction of response/nonresponse to the treatment with an anti-egfr antibody in patients with colorectal cancer of all uicc stages
10/04/2012WO2012131088A1 Method for predicting hypertension
10/04/2012WO2012131087A1 Method for predicting insulinopenic type 2 diabetes
10/04/2012WO2012130984A1 Kinases labeled in the c helix for the screening of inhibitors
10/04/2012WO2012130909A1 Method and means for distinguishing malignant from benign tumor samples, in particular in routine air dried fine needle aspiration biopsy (fnab)
10/04/2012WO2012130887A1 Use of phospho-akt as a biomarker of drug response
10/04/2012WO2012130862A1 Selection of hcv treatment
10/04/2012WO2012130841A1 Improved diffusion layer for an enzymatic in-vivo sensor
10/04/2012WO2012130720A2 PREDICTION OF RESPONSIVENESS TO PIK3/mTOR INHIBITORS
1 ... 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 ... 3003